English to French Pharmaceutical Product Description Translation

What a Pharmaceutical Product Description (or Package Insert) Contains

A pharmaceutical product description, commonly called a package insert, is the official document that accompanies a medicine. It follows a standard structure required by drug regulators worldwide. The typical sections include the drug name, active ingredients (such as sulfadoxine, pyrimethamine, and amodiaquine for antimalarial combinations), dosage form (for example, dispersible tablet), therapeutic indications, posology (dosage regimen), contraindications, special warnings, storage conditions, and manufacturer details. Each section uses precise medical terminology that must be preserved during translation to avoid safety risks. Understanding this structure is essential whether you are translating for a package insert or a regulatory dossier.

Common English Medical Terms in Product Descriptions and Their French Equivalents

The table below lists specialised terms that often appear in antimalarial product inserts. Use this reference to verify that the AI translation has rendered them correctly.

English Term	French Equivalent
sulfadoxine	sulfadoxine
pyrimethamine	pyriméthamine
amodiaquine	amodiaquine
antimalarial	antipaludique
dispersible tablet	comprimé dispersible
composition	composition
storage conditions	conditions de conservation
manufacturer	fabricant
dosage	posologie
package insert	notice d’emballage

Why People Translate Medical Product Descriptions from English to French

Several common scenarios drive the need for English-to-French translation of pharmaceutical product descriptions. An Indian company exporting antimalarials to Francophone African countries such as Senegal, Côte d’Ivoire, or Mali must provide a French-language leaflet that complies with local labelling regulations. Regulatory submissions to the WHO prequalification programme or to the Agence nationale de sécurité du médicament (ANSM) often require complete bilingual documentation. E-commerce sellers listing antimalarials on francophone platforms also need accurate product descriptions in French. In each case, the translation must be faithful to the original medical data to ensure safe use.

AI Translation vs Sworn/Certified Human Work for Pharmaceutical Documents

AI translation from Lekhak delivers an instant, editable French DOCX draft that is ideal for internal review, marketing, or early-stage regulatory preparation. However, final submissions to national drug authorities such as ANSM or to WHO prequalification teams may require a sworn or certified translation from a professional translator, a service Lekhak does not offer. If your regulatory pathway demands a certified version, you will need to engage a credentialed provider separately. The AI draft gives you a fast head start; the decision to certify depends on the specific authority’s requirements.

What Lekhak’s AI Translation Produces for a Product Description

Upload a PDF, image, or Word document containing the English product description to Lekhak’s platform. The AI pipeline extracts the text, recognises tables, and returns a French DOCX file in minutes. The output retains the original section headings, bullet points, and table structure, for instance, a dosing table with age groups and milligram amounts is preserved as a table. Complex drug names like “sulfadoxine–pyrimethamine dispersible tablet” are handled without splitting or mistranslation. The resulting file is ready for your review, proofreading, or further formatting. It is not a certified submission document, but it saves days of manual typing.

Indian Pharmaceutical English Conventions That Affect Translation to French

Pharmaceutical documents produced in India often follow British English conventions. For example, “sulphadoxine” (with “ph”) appears instead of the US spelling “sulfadoxine”. The leaflet may also list “Tablets IP”, the abbreviation for Indian Pharmacopoeia, which a French pharmacist might not recognise without a contextual translation such as “comprimés conforme à la Pharmacopée Indienne”. Brand-specific suffixes or local manufacturing codes also require careful handling. Lekhak’s AI has been trained on multilingual pharmaceutical texts and can adapt these Indian-specific forms into terminology that French-speaking regulators and pharmacists expect. For more on Indian standards, see the Indian Pharmacopoeia Commission guidelines.

Regulatory References: CDSCO and Schedule D Requirements for Drug Product Information

India’s Drugs and Cosmetics Act, 1940 and the rules set by the Central Drugs Standard Control Organization (CDSCO) define what a product description for a medicine marketed in India must include. Schedule D of the Drugs and Cosmetics Rules prescribes the content of a package insert, such as the list of active ingredients, dosage form, indications, and side effects. When an English-language insert that follows these Indian requirements is translated to French, care must be taken not to omit any mandatory field, as French-speaking regulators may also check completeness. The AI translation preserves every visible line from the original, so nothing is accidentally dropped. For more details on CDSCO’s role, visit the CDSCO overview on Wikipedia.

FAQ: English-to-French Pharmaceutical Product Description Translation

Is Lekhak’s AI translation accurate for complex chemical names like sulfadoxine and pyrimethamine?

Yes. The AI recognises pharmaceutical trade names and International Nonproprietary Names (INNs) and treats them as fixed terms, keeping them unchanged or converting them to the accepted French INN (e.g., pyriméthamine).

What file formats can I upload to Lekhak for translation?

You can upload PDF, DOCX, DOC, image files (JPG, PNG, WebP), TXT, and Markdown. The AI extracts text and tables regardless of the source format.

How fast is the translation?

After uploading your file, Lekhak returns the translated DOCX in minutes, not hours or days. The processing time depends on the file size, but it is typically under five minutes.

Does Lekhak provide certified or sworn translations for regulatory submissions?

No. Lekhak’s output is a best-effort AI translation without a human translator’s signature. If your regulatory authority requires a certified translation, you must arrange it separately with a sworn translator.

Can I try Lekhak’s service for free?

Yes. New users receive 250 free credits at signup, no credit card required. That is enough to translate several pages of a product description.

Will the translation preserve the table structure of a dosing or composition table?

Yes. The AI pipeline retains the original table layout, including rows and columns. This is critical for dose tables and ingredient lists where spatial arrangement matters.

How does the AI handle British spellings common in Indian pharmaceutical texts?

The AI is trained to recognise both British and American spellings and produces the French equivalent accordingly. For instance, “sulphadoxine” is mapped to the same French term as “sulfadoxine”.

Are the translated documents editable afterwards?

Yes. The output is a standard DOCX file that you can open, edit, and format in Microsoft Word, Google Docs, or LibreOffice.

Does Lekhak support other language pairs besides English to French?

Yes. Lekhak supports translation from English to over 70 global languages, including French, Spanish, German, and Arabic, as well as 22 Indian languages.

What if my product description contains images or logos?

Images and logos are extracted as placeholders in the DOCX. The translated text appears in the same relative positions, and you can replace the images with French-language versions later.

Related: pricing